Loading clinical trials...
Loading clinical trials...
A Multi-Center, Open-Label Clinical Trial To Determine The Safety of ABX-EGF As Continued Treatment For Patients Who Have Benefited From and Tolerated Prior ABX-EGF Treatment
Conditions
Interventions
Panitumumab (ABX-EGF)
Start Date
March 1, 2004
Primary Completion Date
September 1, 2007
Completion Date
March 1, 2008
Last Updated
September 15, 2008
NCT06305754
NCT06696768
NCT04704661
NCT06842498
NCT07190248
NCT04550494
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions